🇺🇸 FDA
Pipeline program

TSB-9-W1

SUNTSBA20110201

Phase 1 small_molecule completed

Quick answer

TSB-9-W1 for Metastatic Colorectal Cancer is a Phase 1 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
Metastatic Colorectal Cancer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials